Efficacy and Safety of Intrathecal Morphine for Cesarean Delivery: A Narrative Review
Document Type
Article
Publication Date
7-8-2024
Publication Title
Current Pain and Headache Reports
Abstract
Purpose of Review: Pain management is a critical aspect of care during and following a cesarean delivery. Without proper control of pain, individuals can experience poor mobility, increased thromboembolic events, and difficulty caring for the neonate in the postpartum period. There have been multiple methods for pain management for cesarean delivery and intrathecal morphine (ITM) has emerged as a prominent option for post-operative analgesia due to its efficacy, safety, and potential benefits over other treatments. This review analyzes data on efficacy, side effects, and safety of ITM and the pain control alternatives. Recent Findings: A comprehensive literature review was conducted to compare ITM with other analgesic techniques in post-cesarean patients. ITM was found to be as effective or better than other analgesic options, including bilateral quadratus lumborum block (QLB), opioid-free epidural analgesia (CSEA-EDA), and intravenous fentanyl. One study found that both ITM and oral analgesia were effective in pain control and that ITM caused fewer breakthrough pain events but had a longer duration and a greater rate of side effects than oral opioid analgesia. Commonly observed side effects of intrathecal opioids include nausea, vomiting, pruritus, and urinary retention, and it is thought that the adverse effects from intrathecal administration of opioids are short-lived. Summary: ITM may provide a decreased risk of DVT and coagulation by decreasing lower extremity weakness and numbness, thereby decreasing recovery time and increasing mobility. ITM is a safe and effective option for post-cesarean analgesia, with comparable pain relief to alternative forms of pain control, and side effects that are generally manageable. Further research is warranted to explore beneficial combinations with other methods of pain management and optimal dosing strategies.
PubMed ID
38976173
Recommended Citation
Kaye, Alan D.; Lindberg, Anne M.; Shah, Shivam S.; Maitski, Rebecca J.; Pendarvis, Emily B.; Cooley, Jada F.; Amarasinghe, Sam; Patel, Sagar; Palowsky, Zachary; Fox, Charles J.; Ahmadzadeh, Shahab; Shekoohi, Sahar; and Robinson, Christopher L., "Efficacy and Safety of Intrathecal Morphine for Cesarean Delivery: A Narrative Review" (2024). School of Medicine Faculty Publications. 2819.
https://digitalscholar.lsuhsc.edu/som_facpubs/2819
10.1007/s11916-024-01292-w